Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      Global Cognitive and Memory Enhancer Drugs Market Report to 2030 - Opportunity Analysis and Industry Forecasts

      Research and Markets Logo

      News provided by

      Research and Markets

      May 06, 2022, 09:30 ET

      Share this article

      Share this article


      DUBLIN, May 6, 2022 /PRNewswire/ -- The "Cognitive and Memory Enhancer Drugs Market by Product, Application: Global Opportunity Analysis and Industry Forecast, 2021-2030" report has been added to ResearchAndMarkets.com's offering.

      The global cognitive and memory enhancer drug market was valued at $5,079.86 million in 2020, and is projected to reach $8,689.74 million by 2030, registering a CAGR of 5.5% from 2021 to 2030. Cognitive and memory enhancer drugs, supplements, and other substances are claimed to improve cognitive function, particularly executive functions, attention, memory, creativity, or motivation, in healthy individuals. These drugs include a number of different kinds of substances that can increase mental performance and capable of improving or preserving memory, of potentiating learning, or of preventing cognitive decline or dementia.

      The major factors that contribute to the market growth include surge in geriatric population, which is highly prone to neurological disorders such as Alzheimer's. Moreover, rise in adoption of cognitive drugs, owing to their benefits such as improved physical and mental performance, boosts the market growth. However, ethical issues related with the use of such drugs restrain the growth of this market.

      The cognitive and memory enhancer drug market is segmented into product, application, and region. By product, the market is fragmented into Aricept, Exelon, Namenda, Razadyne, Provigil, Ritalin, Adderall, and others. By application, it is segregated into disease treatment, education, sports, and others. Region wise, the cognitive and memory enhancer drug market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

      The key players operating in the global cognitive and memory enhancer drug market include AbbVie, Alterna Script LLC, Ceretropic, Biogen., Johnson & Johnson, Novartis International AG, Pfizer Inc., Takeda Pharmaceutical Company Ltd., Torrent Pharmaceutical, Inc., and Teva Pharmaceutical Industries Ltd. (Cephalon Inc.).

      Key Benefits

      • The report provides an in-depth analysis of the global cognitive and memory enhancer drug market size along with the current trends and future estimations to elucidate the imminent investment pockets
      • It offers market analysis from 2021 to 2030, which is expected to enable the stakeholders to capitalize on the prevailing opportunities in the market
      • A comprehensive analysis on region assists to understand the regional market and facilitate the strategic business planning and determine prevailing opportunities
      • The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global cognitive and memory enhancer drug market

      Key Topics Covered:

      Chapter 1: Introduction

      Chapter 2: Executive Summary

      Chapter 3: Market Overview
      3.1. Market Definition and Scope
      3.2. Key Findings
      3.2.1. Top Winning Strategies
      3.2.2. Top Investment Pockets
      3.3. Market Share Analysis, 2020
      3.4. Market Dynamics
      3.4.1. Drivers
      3.4.1.1. Rapid Growth of Geriatric Population
      3.4.1.2. High Incidence of Neurodegenerative Disorders
      3.4.1.3. Benefits of Smart Drugs
      3.4.2. Restraint
      3.4.2.1. Numerous Ethical Issues
      3.4.3. Opportunity
      3.4.3.1. Effective Strength of the Drugs
      3.4.4. Impact Analyses
      3.4. Covid-19 Impact Analysis

      Chapter 4: Cognitive and Memory Enhancer Drugs Market, by Product
      4.1. Overview
      4.1.1. Market Size and Forecast
      4.2. Aricept
      4.2.1. Key Market Trends, Growth Factors, and Opportunities
      4.2.2. Market Size and Forecast, by Region
      4.2.3. Market Analysis, by Country
      4.3. Exelon
      4.3.1. Key Market Trends, Growth Factors, and Opportunities
      4.3.2. Market Size and Forecast, by Region
      4.3.3. Market Analysis, by Country
      4.4. Namenda
      4.4.1. Key Market Trends, Growth Factors, and Opportunities
      4.4.2. Market Size and Forecast, by Region
      4.4.3. Market Analysis, by Country
      4.5. Razadyne
      4.5.1. Key Market Trends, Growth Factors, and Opportunities
      4.5.2. Market Size and Forecast, by Region
      4.5.3. Market Analysis, by Country
      4.6. Provigil
      4.6.1. Key Market Trends, Growth Factors, and Opportunities
      4.6.2. Market Size and Forecast, by Region
      4.6.3. Market Analysis, by Country
      4.7. Ritalin
      4.7.1. Key Market Trends, Growth Factors, and Opportunities
      4.7.2. Market Size and Forecast, by Region
      4.7.3. Market Analysis, by Country
      4.8. Adderall
      4.8.1. Key Market Trends, Growth Factors, and Opportunities
      4.8.2. Market Size and Forecast, by Region
      4.8.3. Market Analysis, by Country
      4.9. Others
      4.9.1. Key Market Trends, Growth Factors, and Opportunities
      4.9.2. Market Size and Forecast, by Region
      4.9.3. Market Analysis, by Country

      Chapter 5: Cognitive and Memory Enhancer Drugs Market, by Application
      5.1. Overview
      5.1.1. Market Size and Forecast
      5.2. Disease Treatment
      5.2.1. Market Size and Forecast, by Type
      5.2.1.1. Developmental Conditions
      5.2.1.1.1. Market Size and Forecast
      5.2.1.2. Neurodegenerative Disorders
      5.2.1.2.1. Market Size and Forecast
      5.2.2. Market Size and Forecast, by Region
      5.2.3. Market Analysis, by Country
      5.3. Academic Performance
      5.3.1. Market Size and Forecast, by Region
      5.3.2. Market Analysis, by Country
      5.4. Athletic Performance
      5.4.1. Market Size and Forecast, by Region
      5.4.2. Market Analysis, by Country
      5.5. Others
      5.5.1. Market Size and Forecast, by Region
      5.5.2. Market Analysis, by Country

      Chapter 6: Cognitive and Memory Enhancer Drugs Market, by Region

      Chapter 7: Company Profile
      7.1. Allergan plc.
      7.1.1. Company Overview
      7.1.2. Company Snapshot
      7.1.3. Operating Business Segments
      7.1.4. Product Portfolio
      7.1.5. Business Performance
      7.1.6. Key Strategic Moves and Developments
      7.2. Alternascript LLC
      7.2.1. Company Overview
      7.2.2. Company Snapshot
      7.2.3. Operating Business Segments
      7.2.4. Product Portfolio
      7.3. Biogen.
      7.3.1. Company Overview
      7.3.2. Company Snapshot
      7.3.3. Operating Business Segments
      7.3.4. Product Portfolio
      7.3.5. Business Performance
      7.3. Ceretropic
      7.3.1. Company Overview
      7.3.2. Company Snapshot
      7.3.3. Opreating Segmentt
      7.3.4. Product Portfolio
      7.4. Biogen.
      7.4.1. Company Overview
      7.4.2. Company Snapshot
      7.4.3. Operating Business Segments
      7.4.4. Product Portfolio
      7.4.5. Business Performance
      7.4.6. Key Strategic Moves and Developments
      7.5. Johnson & Johnson
      7.5.1. Company Overview
      7.5.2. Company Snapshot
      7.5.3. Operating Business Segments
      7.5.4. Product Portfolio
      7.5.5. Business Performance
      7.5.6. Key Strategic Moves and Developments
      7.6. Novartis International AG
      7.6.1. Company Overview
      7.6.2. Company Snapshot
      7.6.3. Operating Business Segments
      7.6.4. Product Portfolio
      7.6.5. Business Performance
      7.6.6. Key Strategic Moves and Developments
      7.7. Pfizer Inc.
      7.7.1. Company Overview
      7.7.2. Company Snapshot
      7.7.3. Operating Business Segments
      7.7.4. Product Portfolio
      7.7.5. Business Performance
      7.8. Torrent Pharmaceutical, Inc.
      7.8.1. Company Overview
      7.8.2. Company Snapshot
      7.8.3. Operating Business Segments
      7.8.4. Product Portfolio
      7.9. Takeda Pharmaceutical Company Ltd.
      7.9.1. Company Overview
      7.9.2. Company Snapshot
      7.9.3. Operating Business Segments
      7.9.4. Product Portfolio
      7.9.5. Business Performance
      7.9.6. Key Strategic Moves and Developments
      7.10. Teva Pharmaceutical Industries Ltd. (Cephalon Inc.)
      7.10.1. Company Overview
      7.10.2. Company Snapshot
      7.10.3. Operating Business Segments
      7.10.4. Product Portfolio
      7.10.5. Business Performance

      For more information about this report visit https://www.researchandmarkets.com/r/y8l92e

      Media Contact:

      Research and Markets
      Laura Wood, Senior Manager
      [email protected]

      For E.S.T Office Hours Call +1-917-300-0470
      For U.S./CAN Toll Free Call +1-800-526-8630
      For GMT Office Hours Call +353-1-416-8900

      U.S. Fax: 646-607-1907
      Fax (outside U.S.): +353-1-481-1716

      SOURCE Research and Markets

      Modal title

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.